Detalhe da pesquisa
1.
Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.
BMC Cancer
; 22(1): 254, 2022 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264144
2.
Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells.
Int J Mol Sci
; 22(14)2021 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299092
3.
Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
BMC Cancer
; 20(1): 1039, 2020 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33115415
4.
Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
BMC Cancer
; 20(1): 1127, 2020 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33225928
5.
Impact of MnTBAP and Baricitinib Treatment on Hutchinson-Gilford Progeria Fibroblasts.
Pharmaceuticals (Basel)
; 15(8)2022 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36015093
6.
Nuclear Pore Complexes Cluster in Dysmorphic Nuclei of Normal and Progeria Cells during Replicative Senescence.
Cells
; 10(1)2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33466669
7.
Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells.
Cells
; 8(10)2019 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31635416